Rhelion Life Sciences Corp (RHEL.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 03-2021 | 03-2020 | 03-2019 | |
| Cash Flows From Operating Activities | |||
| Depreciation Amortization | 36 | N/A | N/A |
| Accounts receivable | -359 | -21 | 0 |
| Other Working Capital | -369 | 87 | 131 |
| Other Operating Activity | -2,668 | -304 | -167 |
| Operating Cash Flow | $-3,360 | $-238 | $-36 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -87 | N/A | N/A |
| Net Acquisitions | -1,299 | N/A | N/A |
| Purchase Of Investment | -350 | N/A | N/A |
| Sale Of Investment | 1,716 | N/A | N/A |
| Purchase Sale Intangibles | -181 | N/A | N/A |
| Other Investing Activity | 0 | -1,804 | 0 |
| Investing Cash Flow | $-202 | $-1,804 | $0 |
| Cash Flows From Financing Activities | |||
| Change In Short Term Borrowing | N/A | 85 | 35 |
| Debt Repayment | -19 | N/A | N/A |
| Common Stock Issued | 25,072 | 359 | 0 |
| Other Financing Activity | 7,730 | 3,562 | 0 |
| Financing Cash Flow | $32,783 | $4,006 | $35 |
| Beginning Cash Position | 1,963 | 0 | 1 |
| End Cash Position | 31,185 | 1,963 | 0 |
| Net Cash Flow | $29,222 | $1,963 | $-1 |
| Free Cash Flow | |||
| Operating Cash Flow | -3,360 | -238 | -36 |
| Capital Expenditure | -268 | N/A | N/A |
| Free Cash Flow | -3,627 | -238 | -36 |